Intra Cellular Therapies reported $3.32B in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Adamas Pharmaceuticals ADMS:US 239.75M 41.19M
ALKERMES ALKS:US 3.93B 959.72M
Aptinyx Inc APTX:US $ 192.93M 7.74M
Arena Pharmaceuticals ARNA:US $ 4.16B 41.38M
Biocryst Pharmaceuticals BCRX:US $ 2.81B 1B
Biogen BIIB:US $ 52.13B 9.52B
Bristol Myers Squibb BMY:US $ 148.48B 7.52B
Cytokinetics CYTK:US $ 1.42B 244.24M
Esperion Therapeutics ESPR:US $ 596.26M 193.51M
Gilead Sciences GILD:US $ 86.36B 4.99B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Halozyme Therapeutics HALO:US $ 6.47B 491.5M
Intra Cellular Therapies ITCI:US $ 3.32B 573.64M
JAZZ PHA JAZZ:US 10.83B 1.57B
Johnson & Johnson JNJ:US $ 433825.66M 1140.33M
Marinus Pharmaceuticals MRNS:US $ 657.2M 90.12M
Minerva Neurosciences NERV:US $ 99.11M 25.63M
Nektar Therapeutics NKTR:US $ 3.13B 515.22M
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Novartis NVS:US 224.91B 13.69B
Prothena PRTA:US 2.27B 1.17B
Redhill Biopharma RDHL:US 321.43M 20.17M
Supernus Pharmaceuticals SUPN:US $ 1.64B 250.8M
United Therapeutics UTHR:US $ 8.04B 550.55M
Vanda Pharmaceuticals VNDA:US $ 1.2B 370.85M
Zogenix ZGNX:US $ 964.44M 125.02M